Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST003365)

HILIC POSITIVE ION MODE (Analysis AN005515)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10
Fasnall 218	ME881683	0.00	0.02	0.00	9.72	0.00	0.46	0.00	2.55	0.00	0.00
pABA 120	ME881661	0.71	0.64	0.65	1.98	0.68	0.73	0.77	2.80	4.65	0.26
GSK2194069 344	ME881684	5.41	0.00	1.28	0.00	2.30	0.00	0.00	0.00	0.00	0.00
Malonyl-CoA 303	ME881694	3.61	0.25	1.55	0.01	3.19	0.12	0.27	0.00	0.00	0.00
Malonyl-CoA 428	ME881695	2.85	0.19	1.26	0.00	2.37	0.09	0.24	NA	NA	NA
Threonine 102	ME881652	0.68	0.78	0.76	1.45	0.72	0.70	0.61	0.87	0.79	4.00
Niaciamide 106	ME881656	0.82	0.80	0.72	0.75	0.81	0.78	0.74	1.13	1.63	3.40
Pyridoxine 134	ME881671	0.79	0.79	0.81	0.77	0.78	0.90	0.81	1.22	1.42	3.17
Histidine 83	ME881668	0.69	0.67	0.69	1.93	0.67	0.89	0.69	1.16	1.08	3.04
Valine 55	ME881650	0.79	0.77	0.76	1.44	0.78	0.95	0.75	1.12	1.03	2.60
Citrulline 113	ME881673	0.69	0.69	0.57	3.42	0.61	1.12	0.42	0.71	0.51	NA
Citrulline 70	ME881672	0.86	0.81	0.97	3.24	0.92	1.18	0.78	1.11	0.92	0.10
Acetyl-CoA 428	ME881693	1.43	0.88	1.19	0.56	1.28	0.72	0.94	NA	NA	NA
NAD+ 428	ME881689	1.19	1.08	1.17	0.46	1.21	0.91	1.00	NA	NA	NA
NAD+ 524	ME881688	1.47	1.46	1.70	0.77	1.32	1.06	1.35	0.00	0.00	0.00
Acetyl-CoA 303	ME881692	1.73	1.14	1.65	0.96	1.57	0.99	1.13	0.00	0.00	0.00
O-Acetyl-L-carnitine 85	ME881676	1.73	1.48	1.63	0.64	1.73	0.81	1.08	0.03	0.01	0.00
Alanine PARENT POS	ME881645	1.08	1.81	0.96	1.88	1.01	1.18	1.02	0.64	0.04	0.16
Glycine PARENT POS	ME881644	1.11	1.38	1.20	1.56	1.13	1.28	1.09	0.45	0.30	0.19
NADH 348	ME881691	0.81	1.46	0.72	0.75	0.78	1.69	0.78	NA	NA	NA
NADH 649	ME881690	1.15	1.71	1.00	1.06	1.19	2.10	0.97	0.01	0.00	0.00
Penicillin G 289 POS	ME881682	1.11	1.21	1.13	1.08	1.06	1.26	1.10	1.82	1.83	0.00
Cysteine PARENT POS	ME881653	1.25	0.87	1.27	1.09	1.29	0.84	1.16	0.43	0.72	0.66
Pantothenic 202	ME881679	1.20	1.15	1.19	0.84	1.31	0.95	1.16	0.32	0.27	0.76
Puro Heavy 121	ME881687	0.74	1.10	1.46	0.93	1.28	0.99	1.02	0.79	0.65	0.78
Thiamine 122	ME881681	1.01	1.02	1.03	1.02	1.00	1.11	0.97	1.07	0.86	0.94
Doxycycline 321	ME881686	0.70	0.99	1.17	0.83	0.74	0.90	0.80	NA	1.18	1.31
Glutamine 130	ME881663	0.82	0.90	0.72	1.18	1.14	0.86	1.18	0.39	0.96	1.33
Biotin 227	ME881680	1.26	1.10	1.24	1.34	1.37	1.23	1.18	0.69	0.73	0.01
Asparagine 87	ME881659	1.29	1.06	1.30	1.55	1.30	0.90	1.10	1.09	1.00	0.05
Ornithine 70	ME881660	1.33	1.10	1.22	1.42	1.24	1.09	1.23	1.34	0.75	0.01
Choline 60	ME881646	0.87	0.72	0.75	2.13	0.89	1.23	0.63	1.41	0.89	0.98
Proline 70	ME881648	1.00	1.28	0.99	1.76	0.99	1.25	0.94	1.05	0.96	0.28
Glutamine 84	ME881662	1.06	0.94	1.07	1.42	1.07	1.00	0.95	1.04	1.11	0.66
Methionine 104	ME881665	1.03	0.97	1.02	1.79	0.99	1.01	1.00	1.14	0.97	0.54
Serine 60	ME881647	1.10	1.03	1.14	1.64	1.09	0.95	1.02	1.12	1.04	0.39
Valine 72	ME881649	0.88	0.91	0.88	1.66	0.83	1.07	0.87	1.21	1.18	0.93
Tryptophan 146	ME881677	0.96	0.86	0.81	1.94	0.97	1.06	0.89	1.16	1.03	0.75
Tyrosine 136	ME881674	0.98	0.87	1.03	1.82	0.95	0.95	0.87	1.19	1.12	0.71
Phenylalanine 120	ME881669	1.00	1.01	1.08	1.95	0.95	1.19	0.96	1.25	1.35	0.20
Histidine 110 POS	ME881667	0.85	0.87	0.94	1.79	0.89	1.21	0.87	1.14	1.38	0.55
Isoleucine 69	ME881657	0.95	0.98	0.95	1.92	0.94	1.18	0.90	1.19	1.21	0.47
Leucine 86	ME881658	0.94	0.96	0.95	1.83	0.95	1.14	0.94	1.31	1.27	0.49
Folic 295	ME881685	0.97	0.94	0.85	0.96	0.81	1.04	0.88	1.47	1.31	1.21
Niaciamide 80	ME881655	1.02	0.90	0.84	0.91	0.91	0.99	0.93	1.24	1.58	1.11
Pyridoxine 152	ME881670	0.90	0.92	0.89	0.88	0.91	0.97	0.95	1.31	1.55	1.16
Tryptophan 118	ME881678	0.83	0.81	0.84	1.82	0.78	0.89	0.78	0.77	0.85	2.01
Tyrosine 123	ME881675	0.88	0.81	0.90	1.56	0.84	0.88	0.76	0.87	0.93	2.05
Lysine 84	ME881664	0.66	0.73	0.65	1.48	0.62	0.95	0.70	1.39	1.31	1.71
Methionine 61	ME881666	0.95	0.86	0.87	1.60	0.91	0.92	0.79	1.02	0.98	1.41
Threonine 74 POS	ME881651	0.85	0.88	0.91	1.56	0.85	0.88	0.92	1.01	1.05	1.14

Factors:

F1	Sample source:BT-474 Breast cancer cells \| Drug Treatment:1000 nM GSK2194069
F2	Sample source:BT-474 Breast cancer cells \| Drug Treatment:1 uM Fasnall
F3	Sample source:BT-474 Breast cancer cells \| Drug Treatment:200 nM GSK2194069
F4	Sample source:BT-474 Breast cancer cells \| Drug Treatment:40 uM Fasnall
F5	Sample source:BT-474 Breast cancer cells \| Drug Treatment:500 nM GSK2194069
F6	Sample source:BT-474 Breast cancer cells \| Drug Treatment:5 uM Fasnall
F7	Sample source:BT-474 Breast cancer cells \| Drug Treatment:Control
F8	Sample source:BT-474 \| Drug Treatment:40 uM Fasnall
F9	Sample source:NA \| Drug Treatment:Control
F10	Sample source:NA \| Drug Treatment:NA

Data matrix